Clinical Trial Update: Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial is evaluating allergen-specific immunotherapy using an allergen exposure chamber for allergic rhinoconjunctivitis and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Snippet

Sponsor: Wroclaw Medical University | Conditions: Allergic Rhinoconjunctivitis | Phase 4 | Status: RECRUITING